| 1 |
35366783 | Effect of Aspirin on the prevention of pro-thrombotic states in hospitalized COVID-19 patients: Systematic review. | 2022 Apr 1 |
1 |
| 2 |
33902044 | C-Reactive Protein for Prediction or Early Detection of Pre-Eclampsia: A Systematic Review. | 2021 |
1 |
| 3 |
32207583 | Advanced glycation end products derived from serum albumin modification by glucose (AGE-1) reflect clustering of lipid-associated metabolic abnormalities and are decreased in patients treated with acarbose: A cross-sectional study. | 2020 Mar |
2 |
| 4 |
32360116 | Aspirin to Reduce Risk for Sudden Cardiac Death in Athletes With Elevated C-Reactive Protein Levels. | 2020 Sep |
1 |
| 5 |
32552387 | Aspirin enhances the clinical efficacy of anti-tuberculosis therapy in pulmonary tuberculosis in patients with type 2 diabetes mellitus. | 2020 Oct |
2 |
| 6 |
32645080 | Gender difference in ASAS HI among patients with ankylosing spondylitis. | 2020 |
1 |
| 7 |
33373378 | Perioperative changes of response to antiplatelet medication in vascular surgery patients. | 2020 |
2 |
| 8 |
30562044 | The role of aspirin and inflammation on reproduction: the EAGeR trial 1. | 2019 Mar |
4 |
| 9 |
30790162 | Increased exercise-related platelet activation assessed by impedance aggregometry in diabetic patients despite aspirin therapy. | 2019 Apr |
1 |
| 10 |
31196200 | Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer. | 2019 Jun 13 |
1 |
| 11 |
28348498 | Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies. | 2017 Mar 14 |
1 |
| 12 |
26314869 | Effects of Acetylsalicylic Acid Usage on Inflammatory and Oxidative Stress Markers in Hemodialysis Patients. | 2016 Feb |
1 |
| 13 |
26656902 | Does high serum uric acid level cause aspirin resistance? | 2016 Jun |
1 |
| 14 |
23807310 | C-reactive protein as a marker of complicated diverticulitis in patients on anti-inflammatory medications. | 2014 Feb |
4 |
| 15 |
24022862 | Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome. | 2014 Feb |
1 |
| 16 |
24594292 | Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: a population-based study (CoLaus Study). | 2014 Apr |
2 |
| 17 |
23778008 | Aspirin possibly reduces cerebrovascular events in type 2 diabetic patients with higher C-reactive protein level: subanalysis from the JPAD trial. | 2013 Sep |
3 |
| 18 |
23963688 | Aspirin dose increase from 75 to 150 mg suppresses red blood cell contribution to suboptimal platelet response to aspirin in patients with CAD. | 2013 Dec |
1 |
| 19 |
21035882 | Simvastatin administration reduces thromboxane production in subjects taking aspirin: links between aspirin resistance and thrombin generation. | 2012 Jan 12 |
2 |
| 20 |
22681482 | What is the relationship between effects of aspirin, statins, and C-reactive protein? | 2012 |
1 |
| 21 |
21166598 | The effect of aspirin on C-reactive protein in hypertensive patients. | 2011 |
5 |
| 22 |
21226927 | Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy. | 2011 Jan 12 |
1 |
| 23 |
21327631 | The functions of endothelial progenitor cells were significantly improved after treatment with intravenous immunoglobulin and aspirin in children with Kawasaki disease. | 2011 Apr |
2 |
| 24 |
21726166 | Relationship between bilirubin and C-reactive protein. | 2011 Nov |
1 |
| 25 |
20550971 | Aspirin resistance following pediatric cardiac surgery. | 2010 Sep |
1 |
| 26 |
20920644 | Aspirin adherence, aspirin dosage, and C-reactive protein in the first 3 months after acute coronary syndrome. | 2010 Oct 15 |
9 |
| 27 |
19822838 | Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. | 2009 Dec 2 |
1 |
| 28 |
18034847 | Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. | 2008 Aug |
1 |
| 29 |
18308505 | A prospective evaluation of C-reactive protein in the progression of carotid artery stenosis. | 2008 Apr |
1 |
| 30 |
18585504 | An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration. | 2008 Jul |
8 |
| 31 |
18848489 | Six-month response to anti-TNF drugs in axial spondylarthropathy according to the fulfillment or not of New-York criteria for ankylosing spondylitis or French recommendations for anti-TNF use. A "real life" retrospective study on 175 patients. | 2008 Dec |
1 |
| 32 |
19100419 | Incidence of aspirin resistance and its relationship with cardiovascular risk factors and graft function in renal transplant recipients. | 2008 Dec |
1 |
| 33 |
16473396 | Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein. | 2007 |
6 |
| 34 |
16678922 | Association of cardiorespiratory fitness and levels of C-reactive protein: data from the National Health and Nutrition Examination Survey 1999-2002. | 2007 Jan 2 |
1 |
| 35 |
17218028 | The frequency of aspirin resistance and its risk factors in patients with metabolic syndrome. | 2007 Feb 14 |
1 |
| 36 |
17319905 | Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection. | 2007 Mar |
2 |
| 37 |
17615799 | Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. | 2007 May |
2 |
| 38 |
17633905 | [High sensitivity of C-reactive protein in primary prevention]. | 2007 Jun |
6 |
| 39 |
17700214 | C-reactive protein levels increase after exercise testing in patients with increased platelet reactivity. | 2007 Sep |
2 |
| 40 |
16607074 | Lack of significant effect of low doses of aspirin on the concentrations of C-reactive protein in a group of individuals with atherothrombotic risk factors and vascular events. | 2006 Jan |
2 |
| 41 |
16635110 | Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? | 2006 May |
2 |
| 42 |
17087777 | Aspirin reduces anticardiolipin antibodies in patients with coronary artery disease. | 2006 Dec |
2 |
| 43 |
15576654 | Concurrent treatment with renin-angiotensin system blockers and acetylsalicylic acid reduces nuclear factor kappaB activation and C-reactive protein expression in human carotid artery plaques. | 2005 Jan |
2 |
| 44 |
16142873 | Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept. | 2005 Sep |
1 |
| 45 |
16201293 | Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease. | 2005 |
1 |
| 46 |
14742654 | Periodontal disease and biomarkers related to cardiovascular disease. | 2004 Feb |
1 |
| 47 |
15019895 | Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure. | 2004 Mar 15 |
1 |
| 48 |
15136366 | Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes. | 2004 May |
1 |
| 49 |
15550024 | A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial. | 2004 Nov |
1 |
| 50 |
15853546 | C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker. | 2004 May |
1 |